<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/4274</identifier>
				<datestamp>2021-08-31T18:44:30Z</datestamp>
				<setSpec>bovine:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">A randomized trial comparing effects of respiratory disease metaphylaxis with gamithromycin or ceftiofur crystalline free acid on the health, performance, and economic return of auction market-derived stocker calves backgrounded on Missouri pastures</dc:title>
	<dc:creator xml:lang="en">Valencia, Diana M. A.</dc:creator>
	<dc:creator xml:lang="en">Liebstein, Martin L.</dc:creator>
	<dc:creator xml:lang="en">Thompson, Peggy A. R.</dc:creator>
	<dc:creator xml:lang="en">Renter, David G.</dc:creator>
	<dc:subject xml:lang="en">bovine</dc:subject>
	<dc:subject xml:lang="en">BRD</dc:subject>
	<dc:subject xml:lang="en">ceftiofur crystalline free acid</dc:subject>
	<dc:subject xml:lang="en">gamithromycin</dc:subject>
	<dc:subject xml:lang="en">respiratory disease</dc:subject>
	<dc:description xml:lang="en">The objective was to compare gamithromycin (GAM) and ceftiofur crystalline free acid (CCFA) metaphylaxis for controlling bovine respiratory disease (BRD) impacts in auction market-derived steers. Steers (n=240; initial BW = 537.54 ± 60.61 lb [243.82 ± 27.49 kg]) were randomly allocated to 16 pastures randomized to the 2 treatment groups. Caretakers and data analyst were masked to treatments. Data were analyzed using linear models with means ( ± standard errors of means) reported. Following metaphylaxis, 16 steers (GAM, n=3; CCFA, n=13) required treatment for BRD. Mean BRD morbidity was higher (P=0.03) in the CCFA group (10.83 ± 2.84%) compared to the GAM group (2.50 ± 1.43%). Four steers in each group died or were removed from the 59-day trial due to non-BRD health reasons. Average daily gain in steers finishing the study was greater (P=0.03) in GAM (2.90 ± 0.09 lb [1.32 ± 0.04 kg]) vs CCFA (2.57 ± 0.09 lb [1.17 ± 0.04 kg]) steers. Mean net return per head for steers finishing the study was greater (P≤0.01) for GAM ($22.34 ± 6.75) vs CCFA (-$6.67 ± 6.75). Overall, steers administered GAM metaphylaxis had lower morbidity, increased weight gain, and increased net revenue, compared to those given CCFA.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2019-02-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/bovine/article/view/4274</dc:identifier>
	<dc:identifier>10.21423/bovine-vol53no1p10-16</dc:identifier>
	<dc:source xml:lang="en">The Bovine Practitioner; Vol. 53, No. 1 (2019 Spring); 10-17</dc:source>
	<dc:source>0524-1685</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/bovine/article/view/4274/4188</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2019 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
